Immunologic effects of locoregional therapies for unresectable hepatocellular carcinoma.
- DOI
- 10.1016/j.jhepr.2025.101555
- Published
- 2025 Dec
- Container
- JHEP reports : innovation in hepatology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jhepr.2025.101555,
title = {Immunologic effects of locoregional therapies for unresectable hepatocellular carcinoma.},
author = {Schmidt R and Gebauer B and Akbari N and Roderburg C and Torsello GF and Fehrenbach U and Auer TA and Mohr R and Ardila Pardo GL and Lim W and Pivetta F and Can E and Hamm CA and Tacke F and Hamm B and Hammerich L and Savic LJ},
year = {2025},
journal = {JHEP reports : innovation in hepatology},
doi = {10.1016/j.jhepr.2025.101555},
url = {https://doi.org/10.1016/j.jhepr.2025.101555}
}RIS
TY - JOUR TI - Immunologic effects of locoregional therapies for unresectable hepatocellular carcinoma. AU - Schmidt R AU - Gebauer B AU - Akbari N AU - Roderburg C AU - Torsello GF AU - Fehrenbach U AU - Auer TA AU - Mohr R AU - Ardila Pardo GL AU - Lim W AU - Pivetta F AU - Can E AU - Hamm CA AU - Tacke F AU - Hamm B AU - Hammerich L AU - Savic LJ PY - 2025 JO - JHEP reports : innovation in hepatology DO - 10.1016/j.jhepr.2025.101555 UR - https://doi.org/10.1016/j.jhepr.2025.101555 ER -
APA
R, S., B, G., N, A., C, R., GF, T., U, F., TA, A., R, M., GL, A. P., W, L., F, P., E, C., CA, H., F, T., B, H., L, H., & LJ, S. (2025). Immunologic effects of locoregional therapies for unresectable hepatocellular carcinoma.. JHEP reports : innovation in hepatology. https://doi.org/10.1016/j.jhepr.2025.101555
Source records
- pubmed · retrieved 2026-09-26T21:49:45.505Z